The Venture Codex Logo

The Venture Codex

The National Foundation for Cancer Research

5515 Security Lane, Suite 1105, Rockville, MD, 20852, United States

Overview

Research organization focused on cancer discoveries and developments.

Founded

1973

Deals ยท 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Seed
Series A

Geographic focus

United States

Sector focus

Health Care
Medical
Oncology

Investment portfolio

3rounds
NAMEDATESIZE
Acurion
Apr 2026Participated
$4 MSeed
SciTech Development
Jun 2023Led
$3 MOther Equity
TellBio
May 2021Led
$5 MSeries A
Acurion
Apr 2026Participated
$4 MSeed
SciTech Development
Jun 2023Led
$3 MOther Equity
TellBio
May 2021Led
$5 MSeries A
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

The National Foundation for Cancer Research: 3 funding rounds are recorded in the selected participation categories.All available history.
The National Foundation for Cancer Research: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A10
Other Equity10

Monthly Deal Activity

The National Foundation for Cancer Research: 3 deals are recorded across 66 months.All available history.
The National Foundation for Cancer Research: 3 deals are recorded across 66 months. All available history
MonthDeals
May '211
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

The National Foundation for Cancer Research: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

The National Foundation for Cancer Research: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3
AI & Machine Learning1

Deal Size Distribution

The National Foundation for Cancer Research: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

The National Foundation for Cancer Research: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M1
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

The National Foundation for Cancer Research: United States has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

The National Foundation for Cancer Research: United States has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
United States3
The National Foundation for Cancer Research: 10 co-investors are shown, with ARUP Laboratories sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

The National Foundation for Cancer Research: 10 co-investors are shown, with ARUP Laboratories sharing 1 recorded deals. All available history
Co-investorShared deals
ARUP Laboratories1
Asian Fund for Cancer Research1
Bootstrap Ventures1
Crocker Ventures1
Genetron Health1
HRN Family Office1
Mesa Verde Venture Partners1
Pointe Angels1
Storm Lake Capital1
TK & Partners1

Investment Strategy

The National Foundation for Cancer Research: Led accounts for 67% and participating for 33% of round participation.All available history.
The National Foundation for Cancer Research: Led accounts for 67% and participating for 33% of round participation. All available history
CategoryDeals (count)Share (%)
Led267%
Participating133%
The National Foundation for Cancer Research: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
The National Foundation for Cancer Research: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led2100%

Team

Sreekumar Raghavakaimal

Senior Vice President & Chief Development Officer